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Nuclear factor-kappaB (NF-nB) is a critical regulator of innate and adaptive immune function as well as cell proliferation and survival.
The present study demonstrated for the first time that a virus belonging to the Arteriviridae family activates NF-nB in MARC-145 cells and
alveolar macrophages. In porcine reproductive and respiratory syndrome virus (PRRSV)-infected cells, NF-nB activation was characterized
by translocation of NF-nB from the cytoplasm to the nucleus, increased DNA binding activity, and NF-nB-regulated gene expression. NF-nB
activation was increased as PRRSV infection progressed and in a viral dose-dependent manner. UV-inactivation of PRRSV significantly
reduced the level of NF-nB activation. Degradation of InB protein was detected late in PRRSV infection, and overexpression of the dominant
negative form of InBa (InBaDN) significantly suppressed NF-nB activation induced by PRRSV. However, InBaDN did not affect viral
replication and viral cytopathic effect. PRRSV infection induced oxidative stress in cells by generating reactive oxygen species (ROS), and
antioxidants inhibited NF-nB DNA binding activity in PRRSV-infected cells, suggesting ROS as a mechanism by which NF-nB was
activated by PRRSV infection. Moreover, NF-nB-dependent expression of matrix metalloproteinase (MMP)-2 and MMP-9 was observed in
PRRSV-infected cells, an observation which implies that NF-nB activation is a biologically significant aspect of PRRSV pathogenesis. The
results presented here provide a basis for understanding molecular pathways of pathology and immune evasion associated with disease
caused by PRRSV.
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PRRSV is an enveloped, positive-stranded RNAvirus that
is a member of the order Nidovirales, family Arteriviridae,
along with lactate dehydrogenase-elevating virus of mice,
equine arteritis virus, and simian hemorrhagic fever virus.
PRRSV causes one of the most economically important
diseases of swine which is characterized by severe and
sometimes fatal respiratory disease and reproductive failure.
Infection with PRRSV also predisposes pigs to infection by
bacterial and viral pathogens such as Steptococcus suis,
Haemophilus parasuis, Mycoplasma hyopneumoniae, Acti-0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: KleiboekerS@Missouri.edu (S.B. Kleiboeker).nobaccillus pleuropneumoniae, Salmonella spp., and swine
influenza virus (Benfield et al., 1992; Done and Paton, 1995;
Galina et al., 1994; Groschup et al., 1993; Kawashima et al.,
1996; Zeman et al., 1993). The most consistent pathological
lesions caused by PRRSV during acute infection are
interstitial pneumonia and mild lymphocytic encephalitis
(Halbur et al., 1995; Plagemann, 1996; Rossow et al., 1995,
1996). Tissue macrophages and monocytes are the major
target cells during both acute and persistent infection
(Molitor et al., 1997), although pneumocytes and epithelial
germ cells of the testis have also been shown to be infected
(Sur et al., 1996, 1997).
Viruses are known to control cellular signal transduction
pathways, and the NF-nB pathway is a common target of
many viruses. NF-nB is an inducible transcription factor
that plays a key role in inflammation, innate immune
responses, the regulation of cell proliferation, and cell005) 47 – 59
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Activation of NF-nB by viral infection is a key trigger to
inducing type I interferon (IFN) transcription and other
immune responses, including pro-inflammatory cytokines,
chemokines, adhesion molecules, matrix metalloproteinases
(MMPs), cyclooxygenase 2 (COX2), and inducible nitric
oxide synthase (iNOS) (Caamano and Hunter, 2002;
Santoro et al., 2003). These molecules are involved in
initiating adaptive immune responses by recruiting immune
cells to the site of infection. Furthermore, it was recently
demonstrated that temporally activated NF-nB confers an
essential innate antiviral response against cytoplasmic RNA
viruses (human parainfluenza virus type 3 and respiratory
syncytial virus) in an IFN-independent manner, showing the
importance of NF-nB in the innate antiviral response (Bose
et al., 2003).
NF-nB exists as a homodimer or heterodimer comprised
of one or two of five subunits, RelA (p65), p50, RelB, c-
Rel, and p52. The predominant form is a heterodimer
composed of p50 and RelA subunits (Ghosh et al., 1998).
When inactive, NF-nB is sequestered in the cytoplasm by
associating with inhibitory proteins of the InB family,
including InBa, InBh, and InBe, which mask the nuclear
localization signal. In response to a wide range of stress
signals (e.g., lipopolysaccharide (LPS), tumor necrosis
factor (TNF), interleukin (IL)-1, and virus infection), the
inactive NF-nB–InB complex is dissociated via serine
phosphorylation by InB kinase (IKK) and degradation of
InB in proteasomes. These events lead to the unmasking of
the nuclear localization sequence of NF-nB, which then
allows NF-nB to enter the nucleus and activate transcription
of target genes (May and Ghosh, 1998).Fig. 1. NF-nB translocation is induced by PRRSV infection. (A) MARC-145 cells
permeabilized followed by IFA. Nuclear translocation of NF-nB was detected by
specific antibody recognizing the NF-nB p65 subunit. (B) Nuclear translocation of
and PAM cultures. Both cell types were infected with PRRSV at MOI = 0.1. At 5
prepared and subjected to Western blot analysis, as described in Materials and mWhile the immune response against PRRSV is not fully
characterized, experimental work has demonstrated that the
adaptive immune response of PRRSV-infected pigs is
generally ineffective (Horter et al., 2002; Murtaugh et al.,
2002; Wills et al., 1997, 2003). Specific evidence of an
ineffective adaptive immune response includes a slow
neutralizing antibody response, which is typically not
detected until 3 weeks p.i. (Albina et al., 1998b) and does
not reach maximum levels until 10–18 weeks p.i. (Nelson et
al., 1994; Yoon et al., 1995). While the importance of a cell-
mediated response for protection against PRRSV is well
accepted, the effectiveness of this response during the early
phases of disease also appears to be suboptimal (Murtaugh
et al., 2002). For example, the T-cell response to PRRSV is
weak and transient and cannot be re-stimulated for more
than 4 weeks post-challenge (Molitor et al., 1997; Xiao
et al., 2004). Additionally, IFN-g responses of PRRSV-
infected pigs were relatively weak and increased slowly in
comparison to pseudorabies-virus-infected pigs (Meier et
al., 2003). Although the precise mechanisms for the
ineffective nature of the adaptive immune response to
PRRSV are not known, PRRSV evasion of the innate
immune responses, such as the type I IFN response, may set
the stage for subsequent subversion of the adaptive immune
response. Previous studies demonstrated that PRRSV
appears to elicit weak innate interferon and cytokine
responses compared to other viruses such as swine influenza
virus (SIV), porcine respiratory coronavirus (PRCV), trans-
missible gastroenteritis (TGE) virus, and pseudorabies virus
(Albina et al., 1998a; Meier et al., 2003; Van Reeth and
Nauwynck, 2000; Van Reeth et al., 1999, 2002). Because
NF-nB is important for regulation of type I IFN andwere infected with PRRSV at MOI = 0.1. After 48 h, cells were fixed and
confocal laser microscopy with FITC staining following incubation with a
NF-nB detected by Western blot of nuclear extracts from MARC-145 cells
, 24, 36, 48, and 60 (only in PAM) h post-infection, nuclear extracts were
ethods.
S.-M. Lee, S.B. Kleiboeker / Virology 342 (2005) 47–59 49cytokines (Lenardo et al., 1989; Mogensen and Paludan,
2001), we hypothesized that PRRSV infection may inhibit
NF-nB activation to prevent antiviral responses.
The experiments presented herein were designed to
determine if PRRSV infection modulates NF-nB activation
in host cells. After observing NF-nB activation following
PRRSV infection, the mechanisms by which PRRSV
mediates NF-nB activation, as well as the role of NF-nB
activation in PRRSV replication, were studied using a
dominant negative form of InBa. The present study provides
a basis for understanding the molecular pathways of
pathology and immune evasion associated with disease
caused by PRRSV.Fig. 2. NF-nB binding activity increases at the late stage of infection. NF-
nB p65 binding to DNA was determined using the TransAM NF-nB p65
transcription factor assay kit. Nuclear extracts of MARC-145 cells (A) and
PAM cultures (B) were prepared at 5, 24, 36, 48, and 60 (only in PAM) h
post-infection. Results are expressed as the fold increase of binding activity
compared to mock-infected control. These results are representative of three
(MARC-145 cells) or two (PAM cultures) independent experiments. Values
are shown as the mean T SD from triplicate wells. #P < 0.05 compared to
mock-infected control, *P < 0.01 compared to mock-infected control.Results
PRRSV infection stimulates nuclear translocation and DNA
binding activity of NF-jB
Nuclear translocation, which is one of the key steps
during activation of NF-nB, was detected by indirect
fluorescent antibody (IFA) staining following infection with
PRRSV (Fig. 1A). In uninfected MARC-145 cells, p65
staining was predominantly cytoplasmic, whereas PRRSV
infection (multiplicity of infection (MOI) = 0.1) for 48 h
resulted in nuclear localization of NF-nB p65 staining and
increased cytoplasmic staining of NF-nB p65. In Fig. 1B,
Western blot analysis shows that infection with PRRSV led
to accumulation of NF-nB protein in the nucleus. Compared
to uninfected control cells, the amount of NF-nB increased
as PRRSV infection progressed in MARC-145 cells and
PAM cultures. Increased NF-nB concentrations in the
nucleus were apparent at 24 h p.i. in MARC-145 cells and
at 36 h p.i. in PAM cultures. In these (and subsequent)
experiments, cell viability was assessed by trypan blue
staining, and cultures were consistently found to be
approximately 96% viable in mock-infected cells and 92%
in PRRSV-infected cells at 48 h p.i.
To determine if nuclear translocated NF-nB was capable
of binding nB binding motifs following PRRSV infection,
an NF-nB p65 transcription factor assay was performed
using nuclear extracts of MARC-145 cells and PAM
cultures infected with PRRSV. MARC-145 cells and PAM
cultures were either mock-infected or infected with PRRSV
at MOI = 0.1, and nuclear extracts were prepared at the
indicated times after virus infection. Following infection
with PRRSV, NF-nB p65 DNA binding activity increased as
PRRSV infection progressed. Although a slight, though
statistically significant decrease was consistently observed
at 24 h p.i. in PAM cultures (but not MARC-145 cells), the
predominant effect of PRRSV infection in both cell types
was an increase in NF-nB DNA binding activity. As shown
in Fig. 2, significant increases in NF-nB DNA binding
activity in PRRSV-infected cells were measured, especially
at 36 and 48 h p.i, compared with that in mock-infectedcells. At 48 h p.i., NF-nB p65 DNA binding activities
increased 5.7-fold in MARC-145 cells and 2.2-fold in PAM
cultures. The NF-nB DNA binding activity observed in
these assays was ablated by an excess of unlabeled
competitor, but not by an excess of unlabeled noncompetitor
(data not shown). Taken together, these results demonstrated
that PRRSV induces nuclear translocation of NF-nB
followed by increased DNA binding activity of NF-nB
both in MARC-145 cells and PAM cultures.
PRRSV enhances NF-jB-regulated gene expression, and
NF-jB activation by PRRSV is dependent on viral dose and
active viral replication
Translocation into the nucleus allows NF-nB to stimulate
expression of target genes. Thus, an NF-nB reporter assay
was used to determine if PRRSV infection enhanced NF-
nB-regulated gene expression. MARC-145 cells were
transiently transfected with an NF-nB luciferase reporter
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under the control of a CMV promoter. Therefore, luciferase
expression is under control of NF-nB activation. After
transfection, cells were infected with PRRSV for 1 h or left
uninfected. NF-nB-regulated luciferase expression was
significantly enhanced during PRRSV infection at 36 and
48 h p.i. which correlated with an increased level of NF-nB
DNA binding activity (Fig. 3A). NF-nB activity was 2.53-Fig. 3. PRRSV enhances NF-nB-regulated gene expression in a viral dose-
dependent manner. (A) MARC-145 cells were transfected with pNF-nB-
Luc and phRG-TK, then cells were either mock-infected or infected with
PRRSVat MOI = 0.1. Cells were lysed at 5, 24, 36, and 48 h post-infection.
#P < 0.05 compared to mock-infected control, *P < 0.01 compared to
mock-infected control. Results are representative of at least three
independent experiments. (B) MARC-145 cells transfected with NF-nB-
Luc and phRG-TK plasmid were infected with PRRSV or UV-inactivated
PRRSV at MOI = 1, 0.1, and 0.01 for 1 h. After washing with PBS, fresh
medium was added. At 24 h post-infection, cells were lysed. Firefly and
renillar luciferase activities were measured by using a dual luciferase
reporter assay kit. The luciferase assays were performed in triplicate. Firefly
luciferase activity was normalized by renillar luciferase activity. Results are
shown as the relative fold change compared to that of mock-infected cells.
The symbol c indicates P < 0.001 for results from infectious virus
compared to mock-infected controls. The symbols #, *, and k indicate
P values <0.01, <0.001, and <0.05, respectively, for results from UV-
inactivated virus compared to infectious virus. These results are represen-
tative of at least three independent experiments. Each bar represents the
averaged data from one representative experiment. Values are shown as the
mean T SD from triplicate wells.fold and 6.08-fold higher in PRRSV-infected cells at 36 and
48 h p.i. compared to uninfected control cells. These
findings show that PRRSV infection stimulated NF-nB-
regulated gene expression late in infection, which means
that NF-nB activated by PRRSV is transcriptionally active
and functional.
To determine if there was a relationship between PRRSV
replication and NF-nB activation, MARC-145 cells were
infected at various MOIs and NF-nB activation was
monitored by measuring NF-nB-regulated luciferase expres-
sion. As shown in Fig. 3B, a higher MOI resulted in higher
levels of NF-nB activation, suggesting that NF-nB activation
by PRRSV is viral dose-dependent. In some viral infections,
binding of the viral particle to a cellular surface receptor is
sufficient to trigger signaling cascades that activate NF-nB.
To test this possibility, UV-inactivated PRRSV was used to
determine if PRRSV binding to its receptor mediates NF-nB
activation. As shown in Fig. 3B, UV-inactivation of PRRSV
decreased NF-nB activation compared to infection with non-
inactivated (fully infectious) PRRSV. NF-nB-regulated gene
expression was reduced from 3.34-fold to 1.43-fold at MOI =
1, from 1.99-fold to 1.15 at MOI = 0.1, and from 1.42-fold to
0.96-fold at MOI = 0.01. These data demonstrated that NF-
nB levels are elevated primarily as a result of PRRSV
replication and that UV-inactivation of PRRSV significantly
decreased this effect.
IjB proteins are degraded by PRRSV infection
A key step that leads to NF-nB activation in response to
many extracellular stimuli is degradation of InB proteins.
Therefore, it was determined if PRRSV-mediated changes in
the InB proteins correlated with increased NF-nB activity.
Protein levels of InBa, InBh, and InBe were monitored by
Western blot analysis following a time course of infection in
MARC-145 cells and PAM cultures. Results in Fig. 4 show
that InBa, InBh, and InBe were found in uninfected
MARC-145 cells and PAMs and the protein levels were
mostly unchanged throughout the time course. In MARC-
145 cells (Fig. 4A), PRRSV infection resulted in a lower
concentration of InBa at 48 h p.i. compared to uninfected
control cells, suggesting proteosomal degradation of InBa.
This correlated with the highest NF-nB activity at 48 h p.i.
among the time points tested. However, InBa was still
weakly detectable in PRRSV-infected cells at late times p.i.
InBh and InBe remained relatively constant at all time
points in PRRSV-infected MARC-145 cells. In PAM
cultures, degradation of InBa and InBe was detected after
PRRSV infection at 48 h and 60 h p.i. as shown in Fig. 4B.
The degradation of InBh protein was detected at 60 h p.i.
The onset of the degradation of InB proteins correlated with
the NF-nB activation later in PRRSV infection as observed
above. For both MARC-145 cells and PAM cultures, the
same blot was also reacted with an actin-specific antibody to
confirm that comparable amounts of protein were loaded in
each lane.
Fig. 4. InB proteins are degraded in PRRSV-infected cells. MARC-145 cells (A) and PAM (B) cultures were infected with PRRSVat MOI = 0.1. Cytoplasmic
extracts were prepared at indicated time points and subjected to Western blot analysis with antibodies specific for InBa, InBh, or InBq. Anti-actin was included
as a control for sample loading. Western blot analyses were repeated in two independent experiments with similar results. A representative blot is shown.
Fig. 5. Degradation of InBa is required in NF-nB activation induced by
PRRSV. MARC-145 cells were infected with Ad-eGFP or Ad-InBaDN at
different MOI for 16 h and then transfected with pNF-nB LUC plasmid and
phRG-TK plasmid. Cells were then mock-infected or infected with PRRSV
at MOI = 0.1. At 48 h p.i., cells were lysed, and lysates were analyzed for
firefly and renillar luciferase activities using a dual luciferase reporter assay
kit. Firefly luciferase activity was normalized by renillar luciferase activity.
Results are shown as the relative fold change compared to that of mock-
infected cells. For all assays, analysis was performed in triplicate, and
values are shown as mean T SD. These results are representative of at least
three independent experiments. *P < 0.001.
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PRRSV, and blocking NF-jB activation did not affect
PRRSV replication
To determine if NF-nB activation by PRRSV was
dependent on InBa degradation in MARC-145 cells, the
NF-nB pathway was blocked by using an adenovirus vector
expressing a dominant negative form of InBa (Ad-InBaDN)
which lacks both constitutive (Barroga et al., 1995) and
inducible (Brown et al., 1995) phosphorylation sites. Thus,
InBaDN is a potent NF-nB inhibitor. The same adenovirus
vector expressing GFP (Ad-eGFP) instead of InBaDN was
used as a control. MARC-145 cells were infected with Ad-
eGFP or Ad-InBaDN at variousMOIs (1, 10, or 100) for 16 h
and then transfected with pNF-nB Luc plasmid and phRG-
TK plasmid followed by superinfection with PRRSV at
MOI = 0.1. After 48 h, cells were lysed and analyzed for
luciferase activity. Overexpression of InBaDN significantly
suppressed constitutive NF-nB activity compared to that in
the Ad-eGFP, and such InBaDN expressing cells failed to
activate NF-nB in response to PRRSV infection (Fig. 5).
It was then determined if NF-nB was required for efficient
PRRSV replication. Cell culture medium was collected at 0,
5, 24, 36, and 48 h p.i. Production of infectious progeny virus
was determined by serial 10-fold dilutions of viral stocks with
50% tissue culture infectious dose (TCID50) titers calculated
by the method of Reed and Muench (1938) on MARC-145
cells. The results representing three independent experiments
are shown in Fig. 6. The kinetics of PRRSV replication were
compared to that in control cells. The results showed that
neither Ad-eGFP (Fig. 6A) nor Ad-InBaDN (Fig. 6B)
affected PRRSV replication in MARC-145 cells. In addition,
a typical PRRSV-induced CPE was observed in both Ad-
eGFP- and Ad-InBaDN-infected cells. Therefore, this result
showed that blocking the NF-nB pathway by overexpressionof InBaDN does not alter production of PRRSV progeny
viruses.
Oxidative stress induced by PRRSV infection is involved in
NF-jB activation
Intracellular ROS production was detected by staining
with the hydrogen-peroxide-sensitive fluorescent dye
DCFH-DA which is cleaved intracellularly by nonspecific
Fig. 6. NF-nB activation is not essential for PRRSV replication. MARC-
145 cells were infected with Ad-eGFP (A) or Ad-InBaDN (B) at different
MOI for 16 h and then were superinfected with PRRSV at MOI = 0.1 for
1 h. Cell culture medium was collected at 0, 5, 24, 36, and 48 h p.i., with
each time point represented by triplicate samples. Samples were frozen
80 -C and thawed one time, and infectious virus titers were analyzed in
MARC-145 cells. Values are shown as the mean T SD from triplicate wells,
and this experiment was repeated twice with consistent results.
Fig. 7. ROS induction by PRRSV is involved in NF-nB activation. (A)
MARC-145 cells were infected with PRRSV at MOI = 0.1 for 48 h. DCF
fluorescence was measured by fluorescence microscopy. (B) MARC-145
cells were infected at MOI = 0.1 with PRRSV with or without antioxidant
(PDTC or NAC). At 48 h p.i., nuclear extracts were prepared, and NF-nB
p65 binding to DNA was determined using the TransAMTM NF-nB p65
transcription factor assay kit. Results are expressed as the fold increase of
binding activity compared to mock-infected control. *P < 0.001 compared
to untreated PRRSV control. (C) Cell culture medium was collected at 24
and 48 h p.i., with each time point represented by triplicate samples.
Samples were frozen 80 -C and thawed one time, and infectious PRRSV
titers were analyzed in MARC-145 cells. These results are representative of
two independent experiments. Values are shown as the mean T SD from
triplicate samples.
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DCFH to form the fluorescent product DCF (Sawada et al.,
1996). As shown in Fig. 7A, DCF fluorescence was
enhanced in cells infected with PRRSV at 48 h p.i,
suggesting that PRRSV induced ROS production in
MARC-145 cells. To determine if ROS induction by
PRRSV contributed to activation of NF-nB, cells were
treated with antioxidants and NF-nB binding activity was
measured at 48 h p.i. The DNA binding activity of NF-nB
p65 was markedly reduced in PRRSV-infected cells when
treated with the antioxidant PDTC or NAC as shown in
Fig. 7B. The highest concentration of PDTC or NAC used
in this experiment reduced NF-nB activity to less than
30% in PRRSV-infected cells. To rule out that the
observed effect is simply due to inhibition of viral
replication by antioxidants, virus titer was determined at24 and 48 h p.i. (Fig. 7C). PRRSV replication was not
significantly affected by either PDTC or NAC in all
concentration tested.
Fig. 8. PRRSV increases MMP-2 and MMP-9 gene expression through an
NF-nB-dependent pathway. MARC-145 cells were infected with PRRSV
for 48 h at MOI = 0.1, and total RNAwas extracted and treated with DNase
I. Quantitative real-time RT-PCR was performed for MMP-2 or MMP-9
specific primers. Results are expressed as relative fold changes of MMP-2
or MMP-9 mRNA using cyclophilin as an internal control. Values are
shown as the means T SD from triplicate wells and represent two
independent experiments. *P < 0.001 compared to Ad-eGFP/PRRSV-
infected cells.
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NF-jB activation
To investigate a possible biological role of NF-nB
activation in PRRSV pathogenesis, mRNA expression of
MMP-2 and MMP-9 which are regulated by NF-nB were
determined at 48 h p.i. As shown in Fig. 8, MMP-2 and
MMP-9 gene expression were significantly enhanced by
PRRSV infection which increased expression by approx-
imately 13- and 10-fold, respectively. Overexpression of
InBaDN completely blocked MMP-2 and MMP-9 gene
expression. Therefore, these data indicate that the
activation of the NF-nB pathway by PRRSV was
necessary for enhanced mRNA expressions of MMP-2
and MMP-9.Discussion
Virus–host interactions lead to both activation and
inhibition of complex cellular pathways, resulting in
antiviral responses as well as enhanced viral replication
and virulence. Despite years of research, little is known
about intracellular signaling pathways that play key roles
after PRRSV infection and the role of these pathways in
PRRSV pathogenesis. The present study demonstrated for
the first time that a virus belonging to the Arteriviridae
family activates NF-nB in host cells and that potential
mechanisms of PRRSV-mediated NF-nB activation are
derived from the InB protein degradation and ROS
induction. The major target cells of PRRSV in vivo are
tissue macrophages such as PAMs. MARC-145 cells are the
only continuous cell line that is highly permissive for
PRRSV infection (Kim et al., 1993), and they are typicallyused for in vitro experiments of PRRSV as well as virus
maintenance and attenuation in the laboratory. Viruses could
have different effects on NF-nB pathways depending on the
cell type infected as demonstrated in Epstein–Barr virus and
measles virus infection (Devergne et al., 1996; Dhib-Jalbut
et al., 1999; Dreyfus et al., 1999; Fang et al., 2001; Helin et
al., 2001). Therefore, in the present study, both MARC-145
cells and PAM cultures were used to determine if PRRSV
activates the NF-nB pathway. This study showed that
PRRSV infection resulted in increased nuclear translocation
of NF-nB and increased DNA binding activity both in
MARC-145 cells and PAM cultures. In addition, NF-nB-
dependent luciferase expression was significantly increased
in MARC-145 cells by PRRSV infection. Although the NF-
nB reporter assay was not successfully performed in PAM
cultures (due to extremely low transfection efficiencies of
PAM cultures), results presented here clearly demonstrated
that PRRSV activates the NF-nB pathway in both its natural
target cells, PAM, as well as in a continuous cell line,
MARC-145 cells.
Viruses have developed various strategies which lead to
either activation or inhibition of NF-nB-dependent gene
transcription for their benefits (Santoro et al., 2003). The
NF-nB pathway can be activated as a protective response of
the host to viruses. Therefore, some viruses, such as
vaccinia virus, African swine fever virus, influenza A virus,
and mengovirus, have evolved strategies to block NF-nB
activation in order to evade the innate immune response
(Powell et al., 1996; Shisler and Jin, 2004; Wang et al.,
2000; Zoll et al., 2002). The NF-nB pathway can also be
activated directly by viruses. Viruses including HIV,
herpesviruses, hepatitis C virus, encephalomyocarditis
virus, reovirus, dengue virus, West Nile virus, and herpes
simplex virus have evolved strategies to activate NF-nB to
exploit NF-nB for optimized replication, or to control host
cell proliferation and survival to maximize viral progeny
production (Connolly et al., 2000; Goodkin et al., 2003; Jan
et al., 2000; Santoro et al., 2003; Schwarz et al., 1998; Waris
et al., 2003). Despite the importance of the NF-nB pathway
in immune response, it has not been determined if PRRSV
or other arteriviruses modulate this pathway. Previous
studies demonstrated that PRRSV induced weak type I
IFN responses (Albina et al., 1998a; Lee et al., 2004; Miller
et al., 2004; Van Reeth et al., 1999). Therefore, it has been
postulated that PRRSV inhibited the NF-nB pathway to
evade antiviral responses of host cells. However, the present
study provides evidence that PRRSV actually activates the
NF-nB pathway in PAMs, which are primary target cells in
vivo. The synthesis of type I IFN is regulated trascription-
ally and post-transcriptionally, and various transcription
factors such as the interferon regulatory factor (IRF) family
as well as NF-nB may be involved (Hiscott et al., 2003; Kim
et al., 2000; Taniguchi and Takaoka, 2002; Wathelet et al.,
1998). Therefore, it is possible that PRRSV blocks IFN gene
expression at transcriptional and/or post-transcription levels
but does not inhibit the NF-nB pathway.
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induced by increased generation of ROS is involved in the
activation of NF-nB (Ghosh and Karin, 2002; Janssen-
Heininger et al., 2000). Virus infections such as human
immunodeficiency virus (HIV) (Israel and Gougerot-Poci-
dalo, 1997), cytomegalovirus (CMV) (Speir, 2000), influ-
enza virus (Flory et al., 2000), hepatitis B virus (HBV)
(Waris et al., 2001), hepatitis C virus (HCV) (Gong et al.,
2001), Japanese encephalitis virus (Lin et al., 2004), and
herpes simplex virus (Mogensen et al., 2003) activate the
NF-nB pathway through ROS production. Our study
demonstrated that PRRSV generated ROS, and the involve-
ment of ROS in NF-nB activation by PRRSV was
demonstrated by reduced NF-nB binding activity in the
presence of PDTC and NAC. It has been shown that
oxidative stress induced by ROS is associated with viral
pathogenesis in case of influenza virus and HIV (Peterhans,
1997; Schwarz, 1996). However, the role of ROS in PRRSV
pathogenesis remains to be elucidated.
Viruses modulate NF-nB activation through various
mechanisms. Activation of NF-nB is usually mediated by
degradation of InBa in a proteasome-dependent mechanism
after phosphorylation by IKK (Hayden and Ghosh, 2004).
InBa is generally thought to be the major inhibitor of NF-
nB activation. NF-nB activation by influenza virus is
mediated by oxidative radicals and activation of IKK as a
result of overexpression of viral proteins in endoplasmic
reticulum (Flory et al., 2000). The Tax transactivator
oncoprotein of human T-lymphotropic virus-1 activates
NF-nB by interacting directly with IKK (O’Mahony et al.,
2004). HSV-1 induces persistent translocation of NF-nB by
InBa degradation (Patel et al., 1998). In this study, Western
blot analysis of InB protein levels revealed that InBa
protein was degraded in PRRSV-infected cells and the
expression of InBa-DN eliminated NF-nB activation by
PRRSV. This finding demonstrates that NF-nB activation by
PRRSV is mediated at least in part by InBa degradation in
MARC-145 cells and the degradation of InBa, InBh, and
InBe in PAM cultures. This result indicates the possibility
that different molecules are involved in NF-nB activation in
PAM culture infected with PRRSV compared to MARC-
145 cells. However, the precise mechanism through which
PRRSV influences the InB degradation in both cells is
presently unknown.
Some viruses activate the NF-nB pathway through viral
protein-cellular receptor interaction. For instance, HIV
gp120 and EBV gp350 activate NF-nB signaling pathway
through binding to CD4 and CD21 (Bossis et al., 2002;
D’Addario et al., 1999; Sugano et al., 1997). However, it is
unlikely that NF-nB activation by PRRSV is triggered
solely by viral binding to its cognate cellular receptor
because the level of NF-nB activation by PRRSV increased
as PRRSV replication progression was significantly
reduced by UV-inactivation of virus. Therefore, it is
possible that PRRSV replication or viral protein expression
is a prerequisite for activation of the NF-nB pathway.Alternatively, a soluble factor induced by PRRSV could be
responsible for the delayed NF-nB activation.
Previous studies have demonstrated a requirement for
NF-nB activation in viral replication. Influenza virus
infection is dependent on an active NF-nB signaling
pathway (Nimmerjahn et al., 2004). Inhibition of NF-nB
activation blocked influenza virus infection of susceptible
cells, and cells with low NF-nB activity were poorly
susceptible to influenza virus infection (Nimmerjahn et al.,
2004). Efficient replication of HSV-1 is promoted by NF-nB
activation through the InB kinase-InB-p65 pathway (Greg-
ory et al., 2004). However, blocking the NF-nB pathway by
overexpression of dominant negative forms of InBa did not
interfere with PRRSV replication, suggesting that activation
of the NF-nB pathway is non-essential for efficient viral
replication. Similarly, other studies with Japanese encepha-
litis virus or cytomegalovirus demonstrated that NF-nB
activation is not required for efficient viral replication
(Benedict et al., 2004; Liao et al., 2001). Although NF-nB
activation does not play an essential role in PRRSV
replication in vitro, it does not mean that NF-nB has no
contribution to PRRSV pathogenesis in vivo. Macrophages
represent an important source for a variety of soluble
immune mediators, including cytokines, chemokines,
MMPs, and adhesion molecules which often contain NF-
nB binding sites in their promoters (Caamano and Hunter,
2002; Kim and Koh, 2000; Li and Verma, 2002; Mogensen
and Paludan, 2001). The MMPs are a group of zinc- and
calcium-dependent endopeptidases that degrade an extrac-
ellular matrix implicated in tissue remodeling and chronic
inflammation. MMPs, especially MMP-2 and MMP-9, play
a role in immune responses by promoting infiltration of
inflammatory cells (Kumagai et al., 1999). A previous study
demonstrated that PRRSV infection significantly increased
MMP-2 and MMP-9 which correlated with the appearance
of severe histological lung lesions characterized by massive
lymphomononuclear cell infiltration and possible local
immunosuppression in PRRSV-infected pigs. Therefore, it
is possible that MMPs produced in PRRSV-infected cells by
NF-nB activation could mediate the influx of new cells of
the monocyte/macrophage lineage.
It is well established that NF-nB may play a pivotal role
in apoptosis of virus-infected cells. The NF-nB activation
by viruses could be either an anti-apoptotic response to
maximize viral replication by prolonging host cell survival
or pro-apoptotic response as a mechanism to increase virus
spread (Bowie et al., 2004; Mi et al., 2001). In cells infected
with viruses such as Sindbis virus, reovirus, or dengue virus,
apoptosis is facilitated by the activation of NF-nB which
was triggered by viral infection (Connolly et al., 2000; Jan
et al., 2000; Lin et al., 1995, 1998). In others, activated NF-
nB prevents apoptosis and prolongs cell survival (Bowie et
al., 2004; Goodkin et al., 2003; Grimm et al., 2005; Su et
al., 2001; Thomas et al., 2002). PRRSV has been known to
induce apoptosis mostly in bystander cells in vivo (Sirinar-
umitr et al., 1998). It is not known yet whether the activation
S.-M. Lee, S.B. Kleiboeker / Virology 342 (2005) 47–59 55of NF-nB in PRRSV infection plays an anti-apoptotic role
or pro-apoptotic role.
In summary, the present study demonstrated that PRRSV
activates NF-nB via InB degradation inMARC-145 cells and
PAM cultures and that NF-nB activation is not required for
efficient PRRSV replication in vitro. ROS induction likely
contributes to activation of the NF-nB pathway in PRRSV-
infected cells. However, the detailed molecular mechanisms
and viral components underlying NF-nB activation remain to
be elucidated. This study also suggested a possible role of
NF-nB activation in PRRSV pathogenesis by showing that
PRRSV increased MMP-2 and MMP-9 mRNA expression
through the NF-nB pathway. Future studies will confirm if
PRRSVactivates the NF-nB pathway in vivo. Understanding
the role of NF-nB activation following PRRSV infection will
contribute important information about the molecular patho-
genesis of PRRSV infection.Materials and methods
Cells and virus
The MARC-145 cell line, which is a clone of the African
green monkey kidney cell line MA-104, and the HEK-293
cell line, which is derived from human embryonic kidney
cells were cultured and maintained in Dulbecco’s Modified
Eagle medium (DMEM) supplemented with 10% FBS, 0.25
Ag/ml fungizone, 100 U/ml penicillin, 10 Ag/ml streptomy-
cin sulfate, and 5 Ag/ml gentamicin (BioWhittaker Inc.,
Walkersville, MD) and then held at 37 -C in a humidified
5% CO2 incubator.
The PAM cultures were obtained by bronchoalveolar
lavage of 2- to 3-week-old domestic piglets from a PRRSV
negative herd. The lungs were removed from the piglets
immediately after euthanizing by electrocution, and RPMI-
1640 medium (Life Technologies, Grand Island, NY) was
introduced through the main stem bronchi. Bronchoalveolar
lavage fluid was centrifuged at 400  g for 7 min. After
centrifugation, cell pellets were resuspended in RPMI-1640
medium supplemented with 10% fetal bovine serum (FBS),
2 mM l-glutamine, 0.25 Ag/ml fungizone, 100 U/ml
penicillin, 10 Ag/ml streptomycin sulfate, and 5 Ag/ml
gentamicin (BioWhittaker, Walkersville, MD) and plated at
a density of 2–4  105 cells/well in a 24-well Primaria plate
(Becton Dickinson and Company, Franklin Lakes, NJ). The
PAM cultures were confirmed to be PRRSV-negative by
RT-PCR before used in subsequent experiments. PAM
cultures were incubated for 24 h at 37 -C in a humidified
5% CO2 incubator and washed once with complete RPMI-
1640 media before use. All cells were maintained at 37 -C
in a humidified 5% CO2 incubator.
PRRSV isolate 25544 was obtained from clinical cases
submitted to the University of Missouri’s Veterinary
Medicine Diagnostic Laboratory. Virus stocks of PRRSV
were prepared in MARC-145 cells. A low multiplicity ofinfection (MOI < 0.05) was used to prepare viral stocks. For
virus infection, cells were initially adsorbed with virus at the
indicated MOI for 1 h at 37 -C. After 1 h of adsorption, cells
were gently washed with medium. At indicated time points
post-infection (p.i.), culture media were harvested for the
virus titration, and cells were lysed to prepare cellular
extracts.
Adenovirus vectors expressing a dominant negative InBa
or green fluorescent protein (GFP) were kind gifts from Dr.
Steven L. Bachenheimer (University of North Carolina,
USA). Adenovirus stocks were prepared in HEK-293 cells.
NF-jB-dependent luciferase reporter assay
Subconfluent monolayers of MARC-145 cells in a 24-
well plate were transfected with 10 ng of pRL-TK
(Promega, Madison, WI) and 100 ng of pNF-nBluc
(Stratagene, La Jolla, CA) using the Lipofectamine trans-
fection reagent (Invitrogen Carlsbad, CA). The pRL-TK
plasmid contains the Renilla reniformis (sea pansy) lucifer-
ase gene under the transcriptional control of the herpesvirus
thymidine kinase promoter and constitutively expresses low
levels of renillar luciferase. The pNF-nBluc plasmid
contains the firefly luciferase gene under the transcriptional
control of a synthetic promoter containing five direct repeats
of the NF-nB binding element. After transfection, cells were
mock-infected or infected with viruses at the indicated MOI.
At various time points post-infection, cell monolayers were
lysed in 150 Al of passive lysis buffer (Promega, Madison,
WI) followed by cell lysate analysis for both luciferase
activities by using the Dual Luciferase Reporter assay
(Promega, Madison, WI). Luciferase activity was measured
as relative light units (RLUs) using a luminometer (Turner
BioSystems, Inc. Sunnyvale, CA). For all assays, experi-
ments were performed in triplicate. For each experimental
point, the average of the firefly luciferase activity was
divided by the average of sea pansy luciferase activity to
correct for differences in transfection efficiencies. The
resulting ratios were used to compare the expression of
the firefly luciferase gene in virus-infected cells to that
present in uninfected (mock) cells.
Cellular extracts
Cytoplasmic and nuclear protein extracts from MARC-
145 cells and PAM cultures were prepared with the nuclear
extraction kit (Active Motif, Inc., Carlsbad, CA) according
to the manufacturer’s protocol. Protein concentration was
determined by the Bio-Rad protein assay (Bio-Rad, Her-
cules, CA) with bovine serum albumin as a standard.
NF-jB p65 transcription factor assay
NF-nB binding to nB sites was assessed using the Trans-
AM NF-nB p65 transcription factor assay kit (Active Motif,
Inc., Carlsbad, CA). In this assay, an oligonucleotide
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plate. The active form of NF-nB contained in cell extracts
specifically binds to this oligonucleotide and can be
revealed by incubation with antibodies using enzyme-linked
immunosorbent assay technology with absorbance reading.
Ten microgram of nuclear proteins was analyzed for p65
binding to nB oligonucleotide according to the manufactur-
er’s instructions. The specificity of the assay was monitored
by competition with free wild-type nB consensus oligonu-
cleotide or mutated nB consensus oligonucleotide.
Immunofluorescence microscopy
MARC-145 cells were washed three times with PBS,
fixed and permeabilized in cold methanol for 10 min at
4 -C, and washed three times with PBS. Cells were
incubated for 1 h at room temperature (RT) with a 1:500
dilution of primary mouse anti-NF-nB p65 antibody (Santa
Cruz Biotechnology, Santa Cruz, CA). The cells were then
washed five times in PBS followed by incubation for 1 h
with the anti-mouse IgG secondary antibody conjugated
with FITC (Sigma, St. Louis, MO). The cells were washed
again with PBS and then examined with an Olympus 1X70
microscope fitted with a Bio-Rad MRC-600 confocal laser
(Bio-Rad, Hercules, CA).
Western blotting
Western blotting was performed by utilizing a standard
protocol (Davis et al., 1994). Briefly, cytoplasmic or nuclear
extracts were diluted (2:1) in 2 sample buffer and boiled for
5 min. Twenty micrograms of each extract was subjected to
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) and transferred to a nitrocellulose membrane
(Amersham Biosciences, Piscataway, NJ). The membrane
was washed with phosphate-buffered saline–Tween 20
(TPBS), blocked in a solution of TPBS containing 5% nonfat
dry milk, and then washed three times. The membrane was
then incubated with primary antibody overnight at 4 -C or 1 h
at RT, washed three times with TPBS, and incubated with the
secondary antibody horseradish peroxidase (HRP) conjugate
solution for 1 h at RT. Samples were washed three times with
TPBS, and then the signal was detected with the chemilu-
minescent protein detection system (Amersham Biosciences,
Piscataway, NJ). Antibodies used for Western blot are anti-
NF-nB p65 (Santa Cruz Biotechnology, Santa Cruz, CA),
anti-InBa (Cell Signaling, Beverly, MA), anti-InBh (Santa
Cruz Biotechnology, Santa Cruz, CA), anti-InBq (Santa Cruz
Biotechnology, Santa Cruz, CA), anti-rabbit IgG-HRP
(Amersham Biosciences, Piscataway, NJ), and anti-actin
(Sigma, St. Louis, MO).
ROS detection
Cells were treated with 2V,7V-dichlorofluorescein diacetate
(DCFH-DA, Calbiochem, La Jolla, CA) for 15 min andwashed twice with PBS. The cells were observed under a
fluorescence microscope.
Antioxidants
The antioxidants used in this study were N-acetyl-l-
cysteine (NAC; Calbiochem, La Jolla, CA) in PBS and
pyrollidine dithiocarbamate (PDTC; Sigma, St. Louis, MO)
in PBS. Concentrations which did not show cytotoxicity
were used in this study. None of the solvents alone affected
NF-nB activation in the concentrations used in this study
(data not shown).
RNA extraction
Extraction of RNA was performed using Trizol (Invi-
trogen, Carlsbad, CA), and the Nucleospin RNA II kit (BD
Biosciences Inc., Palo Alto, CA) with DNase I digestion
performed directly on the spin column according to the
manufacturer’s instructions.
RNA quantification standards
Heterologous competitor RNA for quantification of
MMP-2, MMP-9, or cyclophilin was synthesized using
the respective real-time RT-PCR primer sequences in a
methodology previously described (Kleiboeker, 2003). The
concentration of purified competitor RNA was estimated
by measuring the absorbance at 260 nm, and the purity
was assessed by determining the ratio of absorbance at
260 nm to the absorbance at 280 nm. Samples were
considered to be relatively pure and suitable for use as
quantification standards if the ratio was 2.0. Following
purification, the RNA was serially diluted in RNase-free
dH2O and stored as aliquots at 80 -C. The number of
molecules of competitor RNA/Al was estimated based on
the RNA concentration and the molecular weight of the
transcript.
Quantitative (TaqMan) RT-PCR
Amplification of 2 Al RNA was performed using the
Qiagen QuantiTect Probe RT-PCR kit (Qiagen Inc., Valen-
cia, CA) with thermocycling, and detection was performed
in a Stratagene Mx4000 (Stratagene Inc., La Jolla, CA).
Samples were analyzed in triplicate. Thermocycling con-
ditions were: 50 -C (30 min), 95 -C (15 min), followed by
40 cycles of denaturation (94 -C, 15 s) and annealing/
extension (60 -C, 60 s). The primers and probe used for 5
exonuclease (TaqMan) amplification of MMP-9 were 5V-
CCACCACAACATCACCTATTGG-3V (forward), 5V-GAA-
GGCGCGGGCAAA-3V (reverse), and 6-FAM-TCCAAAA-
CTACTCGGAAGACTTGCCGC-BHQ1-3V (probe). The
primers and probe used for 5V exonuclease (TaqMan)
amplification of MMP-2 were 5V-CCGTCGCCCATCAT-
CAA-3V (forward), 5V-CAGGTATTGCACTGCCAACTCT-3V
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BHQ1-3 (probe). Amplification of cyclophilin was performed
as previously described (Miller et al., 2004) and was used for
normalization of MMP-2 and MMP-9 transcript quantities.
All oligonucleotide primers were used at a final concentration
of 0.3 AM, and the dual-labeled probes were used at a final
concentration of 0.2 AM. All oligonucleotide primers and
probes were synthesized by Integrated DNA Technologies,
Inc. (Coralville, IA). The relative copy numbers of MMP-2
and MMP-9 compared to cyclophilin were determined as
previously described (Pfaffl, 2001).
Statistical analysis
The Student’s t test was used for the statistical analyses.
P values of less than 0.05 were considered statistically
significant.References
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